← Back to headlines
Eli Lilly Raises Annual Profit Forecast Driven by GLP-1 Drug Growth
Eli Lilly has increased its annual profit forecast, attributing the upward revision to the strong growth and demand for its GLP-1 class of drugs.
30 Apr, 10:55 — 30 Apr, 10:55
Sources
Showing 1 of 1 sources
